"Tracking Charles Akre's Akre Capital Management Portfolio - Q2 2016 Update"
"Chuck Akre’s portfolio increased ~10% from $4.75B to $5.24B this quarter.Visa Inc., Roper Technologies, and CarMax were increased while reducing Colfax Corp.The top two positions are American Tower and Markel. They have both been in the portfolio for over sixteen years.Charles Akre’s Akre Capital Management portfolio increased 10.42% from $4.75B to $5.24B this quarter. Of the 34 positions in the portfolio, 21 are fairly large (more than ~0.5% of the portfolio each). The largest five positions are American Tower (AMT), Markel Corporation (MKL), MasterCard (MA), Moody’s Corporation (MCO), and Dollar Tree (DLTR) and they together account for ~48% of the total portfolio value.Akre coined the term "compounding machines" to describe the type of businesses he invests in. To learn more about that investing style, check out .Below are the highlights of the activity this quarter:Visa Inc. (V): V is a fairly large 5.38% of the portfolio stake. It was established in Q2 2012 at a cost-basis of around $30. Q2 2013 saw a one-third increase at a cost-basis in the low-40s. This quarter saw a huge ~58% increase at prices between $73 and $82. The stock is now at ~$82. For investors attempting to follow Akre, V is a good option to consider for further research.Roper Technologies (ROP): ROP is a fairly large ~5% of the portfolio position first purchased in Q2 & Q3 2014 at prices between $129 and $150. The stake saw incremental buying in the following quarters as well. This quarter saw another ~19% increase at prices between $165 and $185. The stock is now at $182.CarMax Inc. (KMX): The 5.51% KMX stake is a very long-term stake first purchased in 2002. The bulk of the current position was built over the last four quarters at prices between $42 and $68. The stock is now at ~$60.Colfax Corp. (CFX): The medium-sized 3.42% CFX position was first purchased in Q3 2012 and built up over the last four years at prices between $20 and $75. This quarter saw an about-turn: ~20% reduction at prices between $25 and $34. The stock is now at $29.84.Below is a spreadsheet that highlights the changes to Charles Akre's Akre Capital Management US long stock portfolio as of Q2 2016. Please check out  to have an idea on how the portfolio is progressing:To learn more about how to profit from a strategy of cloning hedge fund picks, check out our book ."